The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Daiichi Sankyo Europe GmbHEU/1/20/1424/001-006

Main Information

Trade NameNustendi
Active SubstancesBempedoic Acid
Dosage FormFilm-coated tablet
Licence HolderDaiichi Sankyo Europe GmbH
Licence NumberEU/1/20/1424/001-006

Group Information

ATC CodeL01XC38 isatuximab


License statusAuthorised
Licence Issued27/03/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back